Muriel Lizé

888 total citations
19 papers, 580 citations indexed

About

Muriel Lizé is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Muriel Lizé has authored 19 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Muriel Lizé's work include MicroRNA in disease regulation (4 papers), Genetic and Kidney Cyst Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Muriel Lizé is often cited by papers focused on MicroRNA in disease regulation (4 papers), Genetic and Kidney Cyst Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Muriel Lizé collaborates with scholars based in Germany, United States and Russia. Muriel Lizé's co-authors include Matthias Dobbelstein, G.L. Dixon, Rui Song, Michael Kessel, Ying Wan, Richard M. Harland, Peter Walentek, Lin He, Polina V. Lishko and Nicole Sponer and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Muriel Lizé

17 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muriel Lizé Germany 7 442 332 108 67 54 19 580
T. P. Kazubskaya Russia 15 788 1.8× 513 1.5× 57 0.5× 95 1.4× 29 0.5× 83 928
Anne Laugesen Denmark 8 1.1k 2.6× 192 0.6× 161 1.5× 57 0.9× 33 0.6× 9 1.3k
Motoyuki Ogawa Japan 15 311 0.7× 72 0.2× 168 1.6× 51 0.8× 33 0.6× 36 487
Simona Pedrotti Italy 11 661 1.5× 218 0.7× 44 0.4× 23 0.3× 29 0.5× 14 746
Stef van Lieshout Netherlands 7 243 0.5× 160 0.5× 208 1.9× 71 1.1× 23 0.4× 11 519
Franck Court France 19 888 2.0× 196 0.6× 416 3.9× 35 0.5× 29 0.5× 37 1.0k
Р Ф Гарькавцева Russia 12 366 0.8× 136 0.4× 123 1.1× 33 0.5× 23 0.4× 26 463
Soumen Paul United States 20 923 2.1× 116 0.3× 96 0.9× 38 0.6× 46 0.9× 28 1.1k
Shogo Moriya Japan 14 402 0.9× 298 0.9× 22 0.2× 52 0.8× 17 0.3× 33 505
Ayaka Otsuka Japan 10 413 0.9× 100 0.3× 46 0.4× 90 1.3× 56 1.0× 11 570

Countries citing papers authored by Muriel Lizé

Since Specialization
Citations

This map shows the geographic impact of Muriel Lizé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Lizé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Lizé more than expected).

Fields of papers citing papers by Muriel Lizé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Lizé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Lizé. The network helps show where Muriel Lizé may publish in the future.

Co-authorship network of co-authors of Muriel Lizé

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Lizé. A scholar is included among the top collaborators of Muriel Lizé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Lizé. Muriel Lizé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Thomas, Matthew J., Franziska Herrmann, Katja Koeppen, et al.. (2025). Nerandomilast Paves the Way for Novel Strategies in IPF Drug Discovery. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A4590–A4590.
2.
Hoffmann, Jan, Meshal Ansari, Holger Schlüter, et al.. (2025). A dual role of fibroblast–epithelial crosstalk in acute and chronic lung injury. Journal of Biological Chemistry. 301(8). 110408–110408.
3.
Li, Dan, Hoeke A. Baarsma, Theo de Boer, et al.. (2025). Effects of the P2RX4 antagonist BR11595 in a guinea pig model of chronic asthma. British Journal of Pharmacology. 182(21). 5378–5390. 1 indexed citations
4.
Ansari, Meshal, Diana Santacruz, Werner Rust, et al.. (2024). JUNB O‐GlcNAcylation‐Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis. Advanced Science. 12(5). e2406751–e2406751. 2 indexed citations
5.
Read, Jane, Andrew T. Reid, Claire Thomson, et al.. (2024). Alveolar epithelial cells of lung fibrosis patients are susceptible to severe virus-induced injury. Clinical Science. 138(8). 537–554. 1 indexed citations
6.
Wagner, Willi L., Christian Dullin, Stefan Andreas, & Muriel Lizé. (2021). Three-dimensional assessment of bronchiectasis in a mouse model of mucociliary clearance disorder. ERJ Open Research. 7(1). 635–2020. 1 indexed citations
7.
Adolfs, Youri, Vivian Dambeck, Muriel Lizé, et al.. (2019). Sensory Axon Growth Requires Spatiotemporal Integration of CaSR and TrkB Signaling. Journal of Neuroscience. 39(30). 5842–5860. 6 indexed citations
8.
Riedel, Dietmar, Li Li, Magdalena Wienken, et al.. (2019). Transcription factor TAp73 and microRNA-449 complement each other to support multiciliogenesis. Cell Death and Differentiation. 26(12). 2740–2757. 25 indexed citations
9.
Addante, Annalisa, Frank Wunder, Lisa Dietz, et al.. (2019). Preclinical Efficacy of a GPR4 Antagonist in a Murine Emphysema-Exacerbation Model. A3782–A3782. 1 indexed citations
10.
Addante, Annalisa, Frank Wunder, Sabrina Schroeder, et al.. (2019). Preclinical efficacy of GPR4 antagonist in a short-term mouse emphysema-exacerbation model. PP221–PP221. 2 indexed citations
11.
Marshall, Clayton B., A. Villena, Jennifer A. Pietenpol, et al.. (2018). p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton. Cell Death and Disease. 9(12). 1183–1183. 33 indexed citations
12.
Song, Rui, Peter Walentek, Nicole Sponer, et al.. (2014). miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature. 510(7503). 115–120. 165 indexed citations
13.
Lizé, Muriel, et al.. (2013). MIR449A (microRNA 449a). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2 indexed citations
14.
Lizé, Muriel, et al.. (2011). MicroRNA-449 in cell fate determination. Cell Cycle. 10(17). 2874–2882. 110 indexed citations
15.
Herr, Christian, et al.. (2011). MiR-449a Is A New Marker Of Differentiation And Repair In Bronchial Epithelial Cells. A4218–A4218. 1 indexed citations
16.
Lizé, Muriel, et al.. (2010). MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia. Cell Cycle. 9(22). 4579–4583. 44 indexed citations
17.
Lizé, Muriel, Christian Herr, Robert Bals, & Matthias Dobbelstein. (2010). 38 miR-449 induces apoptosis while triggering a stress and DNA damage response. European Journal of Cancer Supplements. 8(5). 10–10. 1 indexed citations
18.
Lizé, Muriel, et al.. (2009). E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death and Differentiation. 17(3). 452–458. 177 indexed citations
19.
Dönitz, Jürgen, et al.. (2007). EndoNet: an information resource about regulatory networks of cell-to-cell communication. Nucleic Acids Research. 36(Database). D689–D694. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026